United States · FDA National Drug Code directory
SERTRALINE HYDROCHLORIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72865-207_918e3fe6-8b38-4ec8-accb-09b2d82ff404
- Product NDC
- 72865-207
- Form
- TABLET
- Composition / generic term
- sertraline hydrochloride
- Labeler
- XLCare Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210503
- Source listing expiry
- 20261231
Source-listed ingredients
- SERTRALINE HYDROCHLORIDE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET in 1 BOTTLE (72865-207-05) · 72865-207-05
- 180 TABLET in 1 BOTTLE (72865-207-18) · 72865-207-18
- 30 TABLET in 1 BOTTLE (72865-207-30) · 72865-207-30
- 90 TABLET in 1 BOTTLE (72865-207-90) · 72865-207-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →